UV1

N/A

Report date: 2023/10/10 09:16:30

Base Information

Drug NameUV1
Drug Alias NameUV1 synthetic peptide vaccineUV1 vaccine
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell LungSquamous Cell Carcinoma of Head and Neck +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesSweden +[9] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUltimovacs As
China Registration ClassN/A

Develop Information

Active CompaniesUltimovacs AsMartin-Luther-Universitat Halle-Wittenberg
Inactive CompaniesN/A
Active IndicationsSquamous Cell Carcinoma of Head and NeckMesotheliomaMelanoma
Inactive IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A